IFP Advisors
UNCY icon

IFP Advisors’s Unicycive Therapeutics UNCY Stock Holding History

IFP Advisors’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$202 Buy
+43
New +$223 ﹤0.01% 4865

Other funds holding UNCY

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

IFP Advisors's UNCY Position: Q3 2026 in Review

IFP Advisors opened a new position in Unicycive Therapeutics (UNCY) in Q3 2026: 43 shares worth $202. The stake represents ﹤0.01% of the portfolio and ranks #4865 among its holdings.

9 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.

  • IFP Advisors held 43 shares of Unicycive Therapeutics worth $202 as of Q3 2026.
  • Unicycive Therapeutics was a new IFP Advisors position in Q3 2026.
  • Unicycive Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4865 holding.
  • 9 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.